Ondansetron Pharmacokinetics in Pregnant Women and Neonates: Towards a New Treatment for Neonatal Abstinence Syndrome

Ontogeny of oral drug absorption processes in children

(2012) Miriam G Mooij et al.   Expert Opinion on Drug Metabolism & Toxicology

Neonatal Abstinence Syndrome and Associated Health Care Expenditures

(2012) Stephen W. Patrick et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models

(2011) Martin Bergstrand et al.   AAPS Journal

Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome

(2010) Walter K. Kraft et al.   ADDICTION

A Review of Granisetron, 5-Hydroxytryptamine3 Receptor Antagonists, and Other Antiemetics

(2010) Eric S Hsu   AMERICAN JOURNAL OF THERAPEUTICS

Serotonin Receptor Antagonists for the Prevention and Treatment of Pruritus, Nausea, and Vomiting in Women Undergoing Cesarean Delivery with Intrathecal Morphine: A Systematic Review and Meta-Analysis

(2009) Ronald B. George et al.   ANESTHESIA AND ANALGESIA

Population pharmacokinetics of intravenous ondansetron in oncology and surgical patients aged 1−48 months

(2009) John T. Mondick et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

From mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcotics

(2009) Larry F. Chu et al.   Pharmacogenetics and Genomics

Predicting length of treatment for neonatal abstinence syndrome in methadone-exposed neonates

(2008) Neil S. Seligman et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Developmental Changes in Human Liver CYP2D6 Expression

(2008) J. C. Stevens et al.   DRUG METABOLISM AND DISPOSITION